C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/14 (2006.01) A61K 31/501 (2006.01) A61K 31/5377 (2006.01) A61P 35/00 (2006.01) C07D 413/04 (2006.01)
Patent
CA 2567154
The present invention relates to compounds according to the general formula (I), with the definitions of the substituents X, R1 and R2 given below in the text, as well as their physiologically acceptable salts, methods for producing these compounds and their use as pharmaceuticals. These compounds are kinase inhibitors, in particular inhibitors of the kinase CDK2 (cyclin-dependent kinase 2).
L'invention a trait à des composés représentés par la formule générale (I), les substituants X, R?1¿ et R?2¿ étant définis dans le descriptif, et à leurs sels physiologiquement acceptables, à des procédés de production de ces composés et à leur utilisation comme agents pharmaceutiques. Ces composés constituent des inhibiteurs de kinase, en particulier des inhibiteurs de la kinase CDK2 (kinase 2 dépendant des cyclines).
Benard Didier
Bossart Martin
Combeau Cecile
Delaisi Christine
Hoelder Swen
Aventis Pharma S.a.
Kirby Eades Gale Baker
LandOfFree
Novel pyridazinone derivatives as inhibitors of cdk2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel pyridazinone derivatives as inhibitors of cdk2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel pyridazinone derivatives as inhibitors of cdk2 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1707608